Ennov appoints Dr. Oxana Pickeral as Chief Executive Officer, succeeding 27-year founder Olivier Pâris amid accelerating ...
China's drug regulator accepts NCX 470 NDA for review, advancing Nicox's nitric oxide-donating glaucoma drop toward potential ...
Lyell completes LYL273 manufacturing transfer to its Bothell facility, though the Phase 1/2 colorectal cancer trial now faces ...
PerZeption receives NEI SBIR grant to develop a photostress recovery test for AMD on tablet hardware, aiming to detect vision ...
FDA's September 2026 NEJM framework for psychedelic drugs reshapes trial design, REMS requirements, and patient access for ...
Phase 3 study shows aQIVc demonstrated superior immunogenicity against influenza strains in adults 50 and older, with ...
Velocity Clinical and Stitch expand partnership across 70+ sites, achieving a 9-point reduction in no-show rates and boosting ...
FDA clears Prelude's PRT13722 Phase 1 trial in HR-positive breast cancer, advancing the oral KAT6A degrader toward patient ...
The FDA approval of etripamil for PSVT occurred in December, 2025. Investigation about a potential role of etripamil in ...
The problem isn't that fewer women get aortic stenosis. It's that the entire pipeline, from diagnosis to device, was built ...
CONSONANCE's digitally enhanced MS endpoint cut required sample size 24.9%. Here's what that number costs in protocol ...
FDA's August 2026 warning letter to Fresenius Kabi's Ogden, Utah plant exposes how sponsor oversight of CMOs fails long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results